BSX vs WLYB · P/E 20, rev $10.65B vs P/E 15, rev $1.68B
Boston Scientific Corp (BSX) versus John Wiley & Sons B (WLYB) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
John Wiley & Sons B (WLYB) is a publishing company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported WLYB revenue for 2026-04-30 was $1.68B. Net income was $221.6M. Revenue was down 0.1% from 2025-04-30 to 2026-04-30. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
Not investment advice. Open the BSX and WLYB stock pages for the full models.
Not investment advice.